304 related articles for article (PubMed ID: 30168491)
21. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
[TBL] [Abstract][Full Text] [Related]
22. Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal.
Shrestha LB; Yadav GK; Pradhan S; Sharma A; Pandit T; Chhetry R; Khanal B
PLoS One; 2022; 17(3):e0264791. PubMed ID: 35239716
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
[TBL] [Abstract][Full Text] [Related]
24. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
[TBL] [Abstract][Full Text] [Related]
26. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
29. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
30. [Coinfection of hepatitis B and C in HIV-infected patients].
Ockenga J; Stoll M; Tillmann HL; Trautwein C; Manns MP; Schmidt RE
Wien Med Wochenschr; 1997; 147(19-20):439-42. PubMed ID: 9471839
[TBL] [Abstract][Full Text] [Related]
31. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of hepatitis B and hepatitis C virus co-infection in India: A systematic review and meta-analysis.
Desikan P; Khan Z
Indian J Med Microbiol; 2017; 35(3):332-339. PubMed ID: 29063876
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran.
SeyedAlinaghi S; Jam S; Mehrkhani F; Fattahi F; Sabzvari D; Kourorian Z; Jabbari H; Mohraz M
Acta Med Iran; 2011; 49(4):252-7. PubMed ID: 21713737
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value.
Ockenga J; Tillmann HL; Trautwein C; Stoll M; Manns MP; Schmidt RE
J Hepatol; 1997 Jul; 27(1):18-24. PubMed ID: 9252068
[TBL] [Abstract][Full Text] [Related]
35. The APOBEC3B deletion polymorphism is associated with prevalence of hepatitis B virus, hepatitis C virus, Torque Teno virus, and Toxoplasma gondii co-infection among HIV-infected individuals.
Prasetyo AA; Sariyatun R; Reviono ; Sari Y; Hudiyono ; Haryati S; Adnan ZA; Hartono ; Kageyama S
J Clin Virol; 2015 Sep; 70():67-71. PubMed ID: 26305823
[TBL] [Abstract][Full Text] [Related]
36. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia.
Al-Mughales JA
J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691
[TBL] [Abstract][Full Text] [Related]
37. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
[TBL] [Abstract][Full Text] [Related]
38. Epidemiological Features and Risk Factors for Acquiring Hepatitis B, Hepatitis C, and Syphilis in HIV-Infected Patients in Shaanxi Province, Northwest China.
Zhang C; Ren Q; Chang W
Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32197326
[TBL] [Abstract][Full Text] [Related]
39. Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals.
Gillis J; Cooper C; Rourke S; Rueda S; O'Brien K; Collins E; Rachlis A; Hart TA; Raboud J;
Qual Life Res; 2013 Sep; 22(7):1525-35. PubMed ID: 23070749
[TBL] [Abstract][Full Text] [Related]
40. Association of CMV, HBV, or HCV co-infection with vaccine response in adults with well-controlled HIV infection.
Troy SB; Rossheim AE; Siik J; Cunningham TD; Kerry JA
Hum Vaccin Immunother; 2016 May; 12(5):1295-9. PubMed ID: 26751638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
